Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.00 -1.92% 153.00 155.00 157.00 156.00 156.00 156.00 47,727 16:35:16
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 49.2 -56.5 -72.8 - 274

Amryt Pharma Share Discussion Threads

Showing 4701 to 4710 of 6725 messages
Chat Pages: Latest  197  196  195  194  193  192  191  190  189  188  187  186  Older
I thought you were going to stop posting unless there was something of use to say!
"Everyone is entitled to shift their opinions: as John Maynard Keynes once put it, “When the facts change, I change my mind. What do you do, sir?” Until the facts change I trust that the RNS dated 21/5/2019 means that when AMYT eventually relists the share price will be significantly higher (as the RNS promises) than the suspension price. Of course the facts could change before AMYT relists. Of course I can't gamble on the facts staying the same, or changing, because of the suspension. I can only sit and twiddle my thumbs whilst mdalos posts his subjective opinions and figures non stop.
mdalos1 - 14 Jun 2019 - 15:51:11 - 4574 of 4575 Amryt Pharma - AMYT WRONG WRONG AND WRONG I HAVE MY SHAREHOLDER COMMS PACK TO "GO ON"... BEING A BONAFIDE SHAREHOLDER. WHAT A BULL$H!TTE£ YOU ARE FLUTTERBY CLUELESS UNINFORMED HALFWIT AS EVER >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> LOLs. You've left your Caps Lock on. LOLs. You shouldn't have stopped taking your medication. How do you like being in Broadmoor?
Before he deletes them! mdalos1 - 13 Jun 2019 - 18:59:43 - 4567 of 4568 Amryt Pharma - AMYT You happy with losing 66% of your large holding when the time comes then ABC-123 ? That sounds like a "large" 66% to me !! mdalos1 - 13 Jun 2019 - 18:02:04 - 4565 of 4568 Amryt Pharma - AMYT Another poor performance (worsening) to Dec 2018 6-12 months of the same and it would be raising large amounts via the begging bowl again. Conveniently the proposed takeover/acquisition/merger/reverse takeover will fill that begging bowl nicely but with existing UK AIM PIs diluted significantly. Expecting a further "Business Transformation" plan to be announced beyond the Business re-entering Markets. I think we could get seriously shafted :-(
I am really looking forward to the re listing, the management have done all they said they would do albeit a bit slower than we had hoped, this could turn our very well in late 2019 or 2020, I am a large holder here and i tend on staying to see how this all shapes up... I only invest in shares where the management have serious financial skin in the game as the guys do here...I have read the annual report and am happy with the progress to date, slow and steady wins the race
AMYT for me was always a punt on the outcome of the phase III trial for AP101. Existing AMYT shareholders have been promised US$85m if AP101 comes up trumps. That sum is independent of the share price of the relisted AMYT. PS I don't believe mdalos's analysis and figures are correct. AMYT have stated (RNS dated 21/5/2019) that the US$60m placing price will be at a 20% discount to the ESTIMATED value of AMYT prior to the completion of the acquisition of Aegerion. That estimated value is US$120m according to that RNS. Hence, unless AMYT are telling porkies, the consolidation will not affect the increase in value of our AMYT shares on relisting. As usual mdalos twists the facts to suit his agenda. Basically he's a compulsive liar who deletes his posts. Only time will tell if AMYT are also being economical with the truth with regard to their RNS dated 21/5/2019. I'm hoping that the action of the AMYT share price on relisting will be similar to what has happened at VENN. The placing price was significantly higher than the suspension price. This led to a big jump up in the VENN share price when it relisted yesterday. The VENN share price was suspended around 2.6p, but the recent placing was priced at 5.6p and the share price closed today at 5.3p. That's around double the suspension price. How they managed to get a placing away at 5.6p baffles me (and probably baffles mdalos!), but they did (there was no share consolidation with VENN). I'm hopeful that similar happens with AMYT and that my £2.8k becomes worth over £5k when AMYT relists. PPS. AMYT had to consolidate to get the share price higher because of the proposed Nasdaq listing. This consolidation should ensure the placing is priced north of a dollar.
Interesting it seems Marc Summeray Amryt's CMO is being sued for fraud by the state of Massachusetts?
Exactly Waterloo.
Actually you also need to add in the shares and the assets/market cap into the equation of the take over. Te market cap of the two combined will be a lot higher, as will the shares issued to make the acquisition. Lots still unknown
mdalos1, That's just wrong. As you like examples, this is what I believe will occur Before consolidation: Amryt has 276m shares in circulation, share price is 12.5p = market Cap = £34.5 After 6:1 consolidation: Amryt has 276/6 = 46m shares in circulation, market cap remains at £34.5 as assets still the same, thus new consolidated share price = £34.5m / 46m = 75p Whatever happens to Amryt after the deal concludes will be referenced from a starting position of 75p
Chat Pages: Latest  197  196  195  194  193  192  191  190  189  188  187  186  Older
ADVFN Advertorial
Your Recent History
Amryt Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210802 18:17:26